Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: August 1, 2012
Reporting Period: Second Quarter ended June 30, 2012
This filing serves as a cover document announcing the issuance of an Investor News release regarding the Company's second-quarter 2012 results. The detailed financial data is contained in the attached Exhibit 99.1, which is not included in the text of this filing.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being contained within the attached Investor News (Exhibit 99.1).
The Company utilizes the following non-GAAP financial measures to supplement GAAP results:
- EBITDA: Operating income excluding interest, taxes, depreciation, and amortization.
- Free Cash Flow: A measure of cash generation after capital expenditures.
Reconciliations between these non-GAAP measures and the most comparable GAAP measures are included in the attached Investor News and the Cash Flow Statement.
Material Changes
The filing text does not disclose specific material changes, variances, or comparative data versus the prior period. Such analysis is located in the attached Investor News release.
Guidance, Outlook, and Risks
Management Commentary: Management states that the inclusion of non-GAAP measures is intended to enhance user understanding of current financial performance and future prospects, as well as to ensure consistency and comparability with prior periods.
Regulatory Note: The Company explicitly states that non-GAAP measures should not be used as a substitute for or considered superior to GAAP financial measures.
Legal Disclaimer: The attached Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It shall not be deemed incorporated by reference in any other filing.
Investor Verification Checklist
- Review the attached Investor News (Exhibit 99.1) for specific Q2 2012 revenue, EBITDA, and free cash flow figures.
- Verify the reconciliation of non-GAAP measures to GAAP measures as presented in the attached exhibit.
- Confirm the Company's full-year 2012 guidance, if provided in the attached news release.
- Assess any specific risk factors or contingencies detailed in the full press release, as they are not summarized in this Form 6-K cover letter.